Filing Details
enVVeno Medical Corp (NASDAQ:NVNO) filed a Form 8-K with the Securities and Exchange Commission on July 14, 2026, disclosing a material event.
8k filedNASDAQ:NVNO
enVVeno Medical Corp (NVNO) Reports Material Event to SEC
Filing Details enVVeno Medical Corp (NASDAQ:NVNO) filed a Form 8-K with the Securities and Exchange Commission on July 14, 2026, disclosing a material event. Market Context…
Market Context
enVVeno Medical Corp's stock currently trades at $10.90 with a market capitalization of $7.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for enVVeno Medical Corp's stock.
All SEC filings for enVVeno Medical Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NVNO Stock Page
Frequently Asked Questions
Where can I read NVNO's SEC filings?
Browse all filings on our NVNO SEC filings page.
What types of SEC filings does enVVeno Medical Corp file?
Public companies like enVVeno Medical Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.